...
首页> 外文期刊>Cell Communication and Signaling >Human umbilical cord Wharton jelly cells promote extra-pancreatic insulin formation and repair of renal damage in STZ-induced diabetic mice
【24h】

Human umbilical cord Wharton jelly cells promote extra-pancreatic insulin formation and repair of renal damage in STZ-induced diabetic mice

机译:人脐带沃顿果冻细胞促进STZ诱导的糖尿病小鼠胰腺外胰岛素的形成和肾脏损害的修复

获取原文
           

摘要

We evaluated the therapeutic effect and fate of high doses of human umbilical cord Wharton jelly cells (hUCWJCs) after IP administration to streptozotocin (STZ)-induced diabetic mice. Type 1 diabetes (T1D) was induced in Kunming mice via IP injection of STZ. hUCWJCs were labeled with 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI). Diabetic animals with sustained hyperglycemia for at least 2?weeks were administered 1?×?107 Dil-hUCWJCs via intraperitoneal injection. Insulin, glucagon and PDX-1 were detected by immunofluorescence with confocal microscopy. Serum mouse and human C-peptide was assayed in blood collected via intracardiac puncture. Specific β-cell differentiation markers and human DNA were assessed using qPCR performed with 200?ng of target DNA. hUCWJCs migrated to the STZ-damaged organs and contributed to lower blood glucose levels in 30% of the treated mice. Confocal microscopy revealed the presence of resident insulin-positive cells in the liver and kidneys. hUCWJC-treated mice with restored hyperglycemia also showed increased serum mouse C-peptide levels. The qPCR results, particularly in the liver, revealed that after transplantation hUCWJCs upregulated genes of endocrine precursors but failed to express endocrine stage markers. Mice with restored hyperglycemia had reduced urinary volume and lacked glomerular hypertrophy, exhibiting a morphology resembling that of normal glomeruli. Moreover, we also verified that one of the possible mechanisms by which hUCWJCs exert immunosuppressive effects is through down-regulation of the cell surface receptor HLA-1. We confirmed the potential of IP administration of hUCWJCs and the capability of these cells to migrate to damaged tissues and promote insulin secretion from non-pancreatic local cells and to improve renal damage. These findings confer unique therapeutic properties to hUCWJCs, suggesting a promising future in the treatment of diabetes mellitus.
机译:我们对链脲佐菌素(STZ)诱导的糖尿病小鼠进行IP给药后评估了高剂量的人脐带沃顿水母细胞(hUCWJCs)的治疗效果和命运。通过IP注射STZ在昆明小鼠中诱发1型糖尿病(T1D)。 hUCWJC用1,1'-二十八烷基-3,3,3',3'-四甲基吲哚羰花青高氯酸盐(DiI)标记。通过腹膜内注射给予持续高血糖至少2周的糖尿病动物1××107 Dil-hUCWJC。共聚焦显微镜通过免疫荧光检测胰岛素,胰高血糖素和PDX-1。在通过心内穿刺收集的血液中测定血清小鼠和人C肽。使用200 ng靶DNA进行qPCR评估特异性的β细胞分化标记和人类DNA。 hUCWJCs迁移到STZ损伤的器官,并有助于降低30%的治疗小鼠的血糖水平。共聚焦显微镜检查显示肝脏和肾脏中存在胰岛素阳性细胞。 hUCWJC治疗的高血糖症恢复小鼠也显示血清C肽水平升高。 qPCR结果(尤其是在肝脏中)显示,移植后hUCWJCs上调了内分泌前体的基因,但未能表达内分泌阶段的标志物。高血糖症恢复的小鼠尿量减少,肾小球肥大,表现出与正常肾小球相似的形态。此外,我们还证实了hUCWJC发挥免疫抑制作用的可能机制之一是通过下调细胞表面受体HLA-1。我们证实了hUCWJC的IP给药的潜力以及这些细胞迁移到受损组织并促进非胰腺局部细胞分泌胰岛素并改善肾脏损害的能力。这些发现赋予hUCWJC独特的治疗特性,表明在糖尿病治疗方面有希望的未来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号